Invasive fungal disease of the sinus and orbit: a... (2016 study) Skip to main content
Study Br J Ophthalmol 2016

Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus

Trief D, Gray S, Jakobiec F, Durand M, Fay A, Freitag S, et al., Br J Ophthalmol, 2016

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers looked back at the medical records of 24 patients treated over 20 years at one eye and ear hospital to compare two kinds of serious fungal infection of the sinuses and eye socket.

What They Found

In this retrospective review of 24 patients with confirmed invasive fungal disease of the sinus and/or orbit, patients with orbital involvement had a higher death rate than those with sinus-only disease (78.6% vs 20%, p=0.01) and were more likely to have mucormycosis (86% vs 30%, p=0.01). Mortality was 71% with mucormycosis and 29% with Aspergillus, but this difference was not statistically significant (p=0.16). All patients with orbital involvement or mucormycosis were immunosuppressed or had poorly controlled diabetes, and all had a cranial nerve problem or trouble moving the eye. All five transplant patients with orbital infections died, while the two transplant patients with sinus-only infections survived.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study was a retrospective review of only 24 patients at a single hospital, so the comparison of mucormycosis and Aspergillus was not statistically significant and the findings cannot show cause and effect.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Infection
Source Pubmed
PubMed ID 26112869
Year Published 2016
Journal Br J Ophthalmol
MeSH Terms Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Debridement; Eye Infections, Fungal; Female; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Mucorales; Mucormycosis; Orbital Diseases; Retrospective Studies; Risk Factors; Sinusitis

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology